The subcutaneous implantable cardioverter defibrillator (S-ICD) is a completely
extrathoracic device that has recently been FDA approved for the prevention of sudden …

Background Subcutaneous implantable cardioverter defibrillators (S-ICDs) are considered
an alternative to conventional transvenous ICDs (TV-ICDs) in patients not requiring pacing …

Objectives: The purpose of the study was to evaluate the efficacy and safety of the entirely
subcutaneous implantable cardioverter-defibrillator (S-ICD). Background: A new entirely S …

Background: The entirely subcutaneous implantable cardioverter-defibrillator (S-ICD) is the
first implantable defibrillator that avoids placing electrodes in or around the heart. Two large …

Background The subcutaneous implantable cardioverter-defibrillator (S-ICD) was developed
to avoid complications related to transvenous implantable cardioverter-defibrillator (TV-ICD) …

The subcutaneous implantable cardioverter defibrillator (ICD) provides therapy for the
prevention of sudden cardiac death while avoiding the numerous complications associated …

Background: The subcutaneous implantable cardioverter-defibrillator (S-ICD) was
developed to defibrillate ventricular arrhythmias, avoiding drawbacks of transvenous leads …

The completely subcutaneous implantable cardioverter defibrillator (S-ICD) is rapidly
evolving to become a complete alternative for the transvenous ICD (TV-ICD) leaving the …

The subcutaneous implantable cardioverter-defibrillator (S-ICD) has recently been approved
for commercial use in Europe, New Zealand and the United States. It is comprised of a pulse …

Background Implantable cardioverter-defibrillator (ICD) placement is a well-established
therapy for prevention of sudden cardiac death. The subcutaneous implantable cardioverter …